HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Southeast Asia  /  THA

Thailand

Thailand's National AIDS Programme publishes through the HIV Info Hub, which our project queries directly. The national cascade runs a year further than the international estimates. In the overlapping years, the national cascade and the international estimates differ by about eight per cent, a difference expected between a programme register and a modelled estimate and not a sign of error in the register or in the model.

620,000
People living with HIV, 2025
WHO Global Health Observatory
82.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$4.0m
United States HIV disbursements, 2026
ForeignAssistance.gov
$32.2m
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$20m$40m200120042007201020132016201920222025$32.2m$8.9m$21.6m$4.0m
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2001 — — — $38k
2002 $8.1m $7.5m — $165k
2003 $14.4m $6.0m $7.7m $6.6m
2004 $28.3m $1.5m $25.4m $1.7m
2005 $15.5m $8.8m $6.0m $7.5m
2006 $38.0m $5.8m $28.9m $5.0m
2007 $46.6m $8.4m $33.8m $7.9m
2008 $40.2m $7.3m $31.4m $5.9m
2009 $24.7m $4.3m $17.5m $4.3m
2010 $41.6m $5.7m $30.8m $5.5m
2011 $48.5m $6.9m $37.3m $3.2m
2012 $24.0m $5.1m $16.8m $4.1m
2013 $38.0m $4.6m $31.3m $10.8m
2014 $25.5m $776k $23.3m $686k
2015 $2.2m $209k — $482k
2016 $1.8m $68k — $164k
2017 $1.2m $81k — $84k
2018 $623k $6k — $6k
2019 $5.0m $3.9m — $52k
2020 $38.2m $11.3m $25.9m $9.0m
2021 $30.1m $7.6m $21.8m $7.9m
2022 $29.9m $6.7m $23.0m $7.8m
2023 $48.6m $8.0m $38.9m $8.4m
2024 $32.2m $8.9m $21.6m $8.5m
2025 — — — $5.1m
2026 — — — $4.0m

26 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
0500k1m200020032006200920122015201820212024570,000500,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 920,000 810,000 1,000,000 —
2001 900,000 800,000 1,000,000 —
2002 870,000 770,000 980,000 —
2003 840,000 740,000 950,000 —
2004 810,000 710,000 910,000 —
2005 780,000 690,000 880,000 —
2006 760,000 670,000 850,000 —
2007 740,000 660,000 820,000 —
2008 720,000 640,000 800,000 —
2009 700,000 620,000 780,000 —
2010 690,000 610,000 760,000 220,000
2011 670,000 600,000 750,000 240,000
2012 660,000 590,000 740,000 260,000
2013 650,000 580,000 730,000 290,000
2014 640,000 570,000 720,000 310,000
2015 630,000 570,000 710,000 340,000
2016 620,000 560,000 700,000 370,000
2017 610,000 550,000 690,000 390,000
2018 600,000 540,000 690,000 410,000
2019 590,000 530,000 670,000 430,000
2020 590,000 520,000 670,000 440,000
2021 580,000 520,000 660,000 460,000
2022 580,000 510,000 650,000 470,000
2023 570,000 500,000 650,000 480,000
2024 570,000 500,000 650,000 500,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
20%40%60%80%100%2010201220142016201820202022202496.0%88.0%86.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 — 32.0% —
2011 — 36.0% —
2012 — 40.0% —
2013 — 44.0% —
2014 — 48.0% —
2015 — 55.0% —
2016 — 60.0% —
2017 — 65.0% —
2018 75.0% 68.0% 66.0%
2019 79.0% 72.0% 70.0%
2020 80.0% 76.0% 73.0%
2021 84.0% 78.0% 76.0%
2022 88.0% 81.0% 79.0%
2023 92.0% 85.0% 83.0%
2024 96.0% 88.0% 86.0%

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

The national programme record
Thailand HIV Info Hub
0200k400k600k20212022202320242025467,524555,921413,38823,51033,443
  • Number of people on ART (PEPFAR MER TX_CURR)
  • Number of PLHIV who have been diagnosed with HIV
  • Number of PLHIV virally suppressed (VL<1000)
  • Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS)
  • People receiving PrEP
YearNumber of people on ART (PEPFAR MER TX_CURR)Number of PLHIV who have been diagnosed with HIVNumber of PLHIV virally suppressed (VL<1000)Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS)People receiving PrEP
2021 411,991 491,065 339,507 24,475 —
2022 423,935 507,134 363,869 25,134 —
2023 441,635 524,523 385,572 24,886 21,047
2024 454,720 540,755 400,284 24,074 26,821
2025 467,524 555,921 413,388 23,510 33,443

5 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Counts read directly from the national programme's own publication. The counts come from a programme register and are not modelled estimates, so the counts will not match the international series exactly.

Data-quality flags on Thailand

People newly enrolled on ART during the year, 2020 (PEPFAR Panorama Spotlight). The value moved from 445 in 2019 to 6,164 in 2020, a change of more than threefold in a single year. The move from 445 to 6,164 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2019 and 2020 are not comparable. Check the figures by reporting organisation before reading a trend across 2019 and 2020.

HIV tests performed with the result returned to the person, 2020 (PEPFAR Panorama Spotlight). The value moved from 1,752 in 2019 to 103,689 in 2020, a change of more than threefold in a single year. The move from 1,752 to 103,689 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2019 and 2020 are not comparable. Check the figures by reporting organisation before reading a trend across 2019 and 2020.

Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS), 2020 (PEPFAR Panorama Spotlight). The value moved from 319 in 2019 to 5,166 in 2020, a change of more than threefold in a single year. The move from 319 to 5,166 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2019 and 2020 are not comparable. Check the figures by reporting organisation before reading a trend across 2019 and 2020.

Number of people on ART (PEPFAR MER TX_CURR), 2019 (PEPFAR Panorama Spotlight). The value moved from 7,772 in 2018 to 2,450 in 2019, a change of more than threefold in a single year. The move from 7,772 to 2,450 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2018 and 2019 are not comparable. Check the figures by reporting organisation before reading a trend across 2018 and 2019.

Number of people on ART (PEPFAR MER TX_CURR), 2020 (PEPFAR Panorama Spotlight). The value moved from 2,450 in 2019 to 68,023 in 2020, a change of more than threefold in a single year. The move from 2,450 to 68,023 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2019 and 2020 are not comparable. Check the figures by reporting organisation before reading a trend across 2019 and 2020.

Number of people on ART (PEPFAR MER TX_CURR), 2025 (PEPFAR Panorama Spotlight). The value moved from 53,330 in 2024 to 260,981 in 2025, a change of more than threefold in a single year. The move from 53,330 to 260,981 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2024 and 2025 are not comparable. Check the figures by reporting organisation before reading a trend across 2024 and 2025.

People receiving PrEP, 2019 (PEPFAR Panorama Spotlight). The value moved from 91 in 2018 to 534 in 2019, a change of more than threefold in a single year. The move from 91 to 534 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2018 and 2019 are not comparable. Check the figures by reporting organisation before reading a trend across 2018 and 2019.

People receiving PrEP, 2020 (PEPFAR Panorama Spotlight). The value moved from 534 in 2019 to 5,725 in 2020, a change of more than threefold in a single year. The move from 534 to 5,725 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2019 and 2020 are not comparable. Check the figures by reporting organisation before reading a trend across 2019 and 2020.

Number of PLHIV virally suppressed (VL<1000), 2019 (PEPFAR Panorama Spotlight). The value moved from 6,316 in 2018 to 1,786 in 2019, a change of more than threefold in a single year. The move from 6,316 to 1,786 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2018 and 2019 are not comparable. Check the figures by reporting organisation before reading a trend across 2018 and 2019.

Number of PLHIV virally suppressed (VL<1000), 2020 (PEPFAR Panorama Spotlight). The value moved from 1,786 in 2019 to 55,925 in 2020, a change of more than threefold in a single year. The move from 1,786 to 55,925 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2019 and 2020 are not comparable. Check the figures by reporting organisation before reading a trend across 2019 and 2020.

Number of PLHIV virally suppressed (VL<1000), 2025 (PEPFAR Panorama Spotlight). The value moved from 48,010 in 2024 to 235,151 in 2025, a change of more than threefold in a single year. The move from 48,010 to 235,151 is likely to reflect a change in which organisations funded by PEPFAR report the figures, or in the scope of the PEPFAR reporting, so the values for 2024 and 2025 are not comparable. Check the figures by reporting organisation before reading a trend across 2024 and 2025.

Sources of the figures for Thailand

4,067 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 811 30 2000–2024 aidsinfo.unaids.org 2026-10-20
PEPFAR results by province Programme record 728 7 2016–2025 data.pepfar.gov 2026-10-12
WHO Global Health Observatory Modelled estimate 262 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 172 17 2000–2025 extranet.who.int 2026-10-16
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 96 16 2018–2023 hivfinancial.unaids.org 2026-10-12
ForeignAssistance.gov Expenditure account 87 5 2001–2026 foreignassistance.gov 2026-10-29
Global Fund Data Service Programme record 72 9 2017–2025 fetch.theglobalfund.org 2026-10-12
IATI, through d-portal Expenditure account 65 3 2000–2026 d-portal.org 2026-10-12
OECD Creditor Reporting System Expenditure account 63 3 2002–2024 sdmx.oecd.org 2026-10-12
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
PEPFAR testing by modality Programme record 48 6 2018–2025 data.pepfar.gov 2026-10-12
PEPFAR Panorama Spotlight Programme record 47 6 2018–2025 data.pepfar.gov 2026-10-12
WHO HIV testing services dashboard Programme record 47 5 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
PEPFAR results by funding agency Programme record 42 6 2018–2025 data.pepfar.gov 2026-10-12
PEPFAR budgets and expenditure Expenditure account 30 6 2021–2025 data.pepfar.gov 2026-10-12
Thailand HIV Info Hub Programme record 23 5 2021–2025 hivhub.ddc.moph.go.th 2026-10-12
UNAIDS Data 2025 country databook Expenditure account 18 3 2018–2023 aidsinfo.unaids.org 2026-10-15
PEPFAR commodity procurement plans Expenditure account 16 4 2020–2025 data.pepfar.gov 2026-10-12
PEPFAR operating-unit budgets Expenditure account 6 2 2010–2020 data.pepfar.gov 2026-10-12
Global Fund allocations Expenditure account 4 1 2017–2026 fetch.theglobalfund.org 2026-10-12
PEPFAR human resources for health inventory Expenditure account 3 3 2025 data.pepfar.gov 2026-10-12

Indicators held

100 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Actual expenditure on collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $288k (2024)
Budget required for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $171k (2025)
Country-reported HIV expenditure, all sources Financing USD 14 2012–2023 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $248.8m (2023)
Domestic funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $22.7m (2024)
Domestic public HIV expenditure Financing USD 12 2018–2023 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $225.2m (2023)
Expected Global Fund funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $4.6m (2025)
Expected USAID funding for the national TB programme Financing USD 3 2018–2020 WHO Global Tuberculosis Programme $0 (2020)
Expected domestic funding for the national TB programme Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $25.8m (2025)
Expected funding for collaborative TB/HIV activities Financing USD 8 2018–2025 WHO Global Tuberculosis Programme $171k (2025)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $32.2m (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 26 2000–2025 IATI, through d-portal $0 (2025)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $31k (2026)
External HIV financing from the United States (ODA) Financing USD 49 2001–2026 ForeignAssistance.gov, OECD Creditor Reporting System $4.0m (2026)
Funding received for collaborative TB/HIV activities Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $952k (2024)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 4 2017–2026 Global Fund allocations 26,068,009 (2026)
Global Fund HIV disbursements to the country Financing USD 47 2003–2026 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $5.4m (2026)
Global Fund funding received by the national TB programme Financing USD 8 2017–2024 WHO Global Tuberculosis Programme $5.2m (2024)
HIV spending on TB/HIV co-infection Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $227k (2023)
HIV spending on community mobilisation and system strengthening Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $15k (2023)
HIV spending on critical enablers Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $2.7m (2023)
HIV spending on gender programmes Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $40k (2023)
HIV spending on governance and sustainability Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $8.1m (2023)
HIV spending on prevention Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $36.4m (2023)
HIV spending on prevention of vertical transmission Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $929k (2023)
HIV spending on programmes for children and adolescents Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $38k (2023)
HIV spending on social protection and economic support Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $14.4m (2023)
HIV spending on treatment, care and support Financing USD 6 2018–2023 UNAIDS Global AIDS Monitoring expenditure database $186.0m (2023)
International HIV expenditure (country-reported) Financing USD 12 2018–2023 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $23.1m (2023)
PEPFAR expenditure, HHS/CDC Financing USD 5 2021–2025 PEPFAR budgets and expenditure $1.6m (2025)
PEPFAR expenditure, USAID Financing USD 5 2021–2025 PEPFAR budgets and expenditure $4.2m (2025)
PEPFAR expenditure, all US agencies Financing USD 12 2018–2025 PEPFAR budgets and expenditure, PEPFAR operating-unit budgets, UNAIDS Global AIDS Monitoring expenditure database $5.8m (2025)
PEPFAR planned commodity procurement, like for like Financing USD 4 2020–2025 PEPFAR commodity procurement plans $116k (2025)
PEPFAR planned funding (budget), all US agencies Financing USD 10 2010–2025 PEPFAR budgets and expenditure, PEPFAR operating-unit budgets $12.8m (2025)
PEPFAR planned funding, HHS/CDC Financing USD 5 2021–2025 PEPFAR budgets and expenditure $5.2m (2025)
PEPFAR planned funding, USAID Financing USD 5 2021–2025 PEPFAR budgets and expenditure $7.6m (2025)
PEPFAR planned procurement of antiretroviral drugs Financing USD 4 2020–2025 PEPFAR commodity procurement plans $0 (2025)
PEPFAR planned procurement of laboratory commodities Financing USD 4 2020–2025 PEPFAR commodity procurement plans $0 (2025)
PEPFAR planned procurement of rapid test kits Financing USD 4 2020–2025 PEPFAR commodity procurement plans $116k (2025)
PEPFAR spend on staff, human resources for health inventory Financing USD 1 2025 PEPFAR human resources for health inventory $2.9m (2025)
PEPFAR-funded staff delivering services, full-time equivalents Financing count 1 2025 PEPFAR human resources for health inventory 79 (2025)
PEPFAR-funded staff, full-time equivalents Financing count 1 2025 PEPFAR human resources for health inventory 207 (2025)
Private HIV expenditure (country-reported) Financing USD 12 2018–2023 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $487k (2023)
US HIV disbursements managed by Health and Human Services Financing USD 23 2003–2026 ForeignAssistance.gov $406k (2026)
US HIV disbursements managed by USAID Financing USD 25 2001–2026 ForeignAssistance.gov $-1 (2026)
US HIV disbursements managed by other US agencies Financing USD 11 2005–2016 ForeignAssistance.gov $0 (2016)
US HIV disbursements managed by the State Department Financing USD 2 2025–2026 ForeignAssistance.gov $3.6m (2026)
USAID funding received by the national TB programme Financing USD 2 2018–2019 WHO Global Tuberculosis Programme $0 (2019)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 15 2018–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 81.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 72 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 82.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 19 2018–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 90.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 19 2006–2024 UNAIDS AIDSinfo 60.2% (2024)
% of people currently enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 2 2023–2024 UNAIDS AIDSinfo 0.6% (2024)
% of people living with HIV on ART who completed a course of TB preventive therapy Treatment cascade percent 2 2023–2024 UNAIDS AIDSinfo 90.1% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 4 2013–2018 UNAIDS AIDSinfo 22.4% (2018)
% of people newly enrolled in HIV treatment started on TB preventive therapy Treatment cascade percent 3 2019–2024 UNAIDS AIDSinfo 6.3% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 104 2017–2025 PEPFAR results by province, WHO Global Health Observatory 98.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 34 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 1.4% (2024)
HIV self-test kits distributed Treatment cascade count 2 2018–2024 WHO HIV testing services dashboard 433,903 (2024)
HIV tests performed at a health facility Treatment cascade count 13 2018–2025 PEPFAR testing by modality, WHO HIV testing services dashboard 25,691 (2025)
HIV tests performed through community outreach Treatment cascade count 12 2018–2025 PEPFAR testing by modality, WHO HIV testing services dashboard 13,879 (2025)
HIV tests performed with the result returned to the person Treatment cascade count 171 2016–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 766,575 (2025)
HIV-exposed infants tested within two months of birth Treatment cascade percent 15 2010–2024 UNAIDS AIDSinfo 87.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 24 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 4,281 (2025)
Key-population people tested for HIV (count over the period) Treatment cascade count 23 2017–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 6 2015–2020 UNAIDS AIDSinfo 53.0% (2020)
Newly diagnosed at HHS/CDC-funded partners (MER HTS_TST_POS) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 11,324 (2025)
Newly diagnosed at USAID-funded partners (MER HTS_TST_POS) Treatment cascade count 6 2020–2025 PEPFAR results by funding agency 458 (2025)
Newly enrolled on ART at HHS/CDC-funded partners (MER TX_NEW) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 10,113 (2025)
Newly enrolled on ART at USAID-funded partners (MER TX_NEW) Treatment cascade count 6 2020–2025 PEPFAR results by funding agency 175 (2025)
Number newly diagnosed HIV-positive (PEPFAR MER HTS_TST_POS) Treatment cascade count 139 2016–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, PEPFAR testing by modality, Thailand HIV Info Hub 23,510 (2025)
Number of PLHIV virally suppressed (VL<1000) Treatment cascade count 109 2017–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, Thailand HIV Info Hub 413,388 (2025)
Number of PLHIV who have been diagnosed with HIV Treatment cascade count 5 2021–2025 Thailand HIV Info Hub 555,921 (2025)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 202 2000–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, Thailand HIV Info Hub, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO Global Tuberculosis Programme 508,619 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 95.0% (2025)
People living with HIV in care screened for TB Treatment cascade count 4 2017–2023 Global Fund Data Service 28,061 (2023)
People living with HIV on ART who started TB preventive therapy Treatment cascade count 8 2018–2025 Global Fund Data Service 6,571 (2025)
People newly diagnosed at a health facility Treatment cascade count 8 2018–2025 PEPFAR testing by modality 417 (2025)
People newly diagnosed through community outreach Treatment cascade count 8 2018–2025 PEPFAR testing by modality 41 (2025)
People newly enrolled on ART during the year Treatment cascade count 125 2013–2025 PEPFAR Panorama Spotlight, PEPFAR results by province, WHO Global Tuberculosis Programme 10,288 (2025)
People on ART at HHS/CDC-funded partners (MER TX_CURR) Treatment cascade count 8 2018–2025 PEPFAR results by funding agency 260,774 (2025)
People on ART at USAID-funded partners (MER TX_CURR) Treatment cascade count 6 2020–2025 PEPFAR results by funding agency 207 (2025)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 9 2015–2024 UNAIDS AIDSinfo 98.0% (2024)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 2,153 (2025)
TB patients recorded as HIV-positive Treatment cascade count 15 2015–2024 WHO Global Tuberculosis Programme 5,172 (2024)
TB patients with an HIV test result recorded Treatment cascade count 21 2015–2025 Global Fund Data Service, WHO Global Tuberculosis Programme 63,382 (2025)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 8,400 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 1,400 (2024)
HIV prevalence among a key population Epidemic estimates percent 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 1.0% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 7,600 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 7,300 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 620,000 (2025)
Key-population members reached by prevention programmes Prevention and outreach percent 4 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Key-population people reached by outreach (count over the period) Prevention and outreach count 2 2017 Global Fund Data Service By population group, sex or age only, to 2017
Male condoms distributed in a year Prevention and outreach count 3 2022–2024 UNAIDS AIDSinfo 55,915,904 (2024)
People receiving PrEP Prevention and outreach count 101 2017–2025 Global Fund Data Service, PEPFAR Panorama Spotlight, PEPFAR results by province, Thailand HIV Info Hub, UNAIDS AIDSinfo 33,443 (2025)
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 31 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 2,200 (2025)
Estimated size of a key population Population denominators count 5 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 71,619,863 (2025)
Share of HIV-exposed infants who acquire HIV — percent 31 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 1.8% (2025)

Every row shown on the Thailand page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.